1. Home
  2. SFBC vs PLYX Comparison

SFBC vs PLYX Comparison

Compare SFBC & PLYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sound Financial Bancorp Inc.

SFBC

Sound Financial Bancorp Inc.

HOLD

Current Price

$45.30

Market Cap

103.8M

Sector

Finance

ML Signal

HOLD

Logo Polaryx Therapeutics Inc. Common Stock

PLYX

Polaryx Therapeutics Inc. Common Stock

N/A

Current Price

$2.12

Market Cap

112.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SFBC
PLYX
Founded
1953
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
103.8M
112.7M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
SFBC
PLYX
Price
$45.30
$2.12
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
8.8K
91.4K
Earning Date
04-28-2026
05-22-2026
Dividend Yield
2.04%
N/A
EPS Growth
53.89
N/A
EPS
0.61
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$75.23
N/A
Revenue Growth
N/A
N/A
52 Week Low
$40.68
$1.86
52 Week High
$48.85
$9.18

Technical Indicators

Market Signals
Indicator
SFBC
PLYX
Relative Strength Index (RSI) 47.27 35.30
Support Level $43.81 N/A
Resistance Level $44.93 $2.91
Average True Range (ATR) 1.57 0.19
MACD -0.24 -0.02
Stochastic Oscillator 22.09 21.31

Price Performance

Historical Comparison
SFBC
PLYX

About SFBC Sound Financial Bancorp Inc.

Sound Financial Bancorp Inc operates as the holding company for Sound Community Bank that provides traditional banking and other financial services for individuals and businesses. It attracts retail and commercial deposits from the public and invests those funds, along with borrowed funds, in loans secured by first and second mortgages on one-to-four-family residences including home equity loans and lines of credit, commercial and multifamily real estate, construction and land, consumer and commercial business loans. The bank also offers secured and unsecured consumer loan products, including manufactured home loans, floating home loans, automobile loans, boat loans, and recreational vehicle loans.

About PLYX Polaryx Therapeutics Inc. Common Stock

Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the underlying pathophysiology of these diseases and addressing unmet needs. The company's therapeutic pipeline includes PLX-200, PLX-300, and PLX-100, which are orally available small-molecule drug candidates designed to address core pathological mechanisms common to LSDs. The Company has one reportable segment: lysosomal storage disorders. The lysosomal storage disorders segment consists of the Company's costs associated with the preclinical and clinical development of the Company's product candidates.

Share on Social Networks: